These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 871824)

  • 1. Circulating immune complexes after repeated halothane anaesthesia.
    Williams BD; White N; Amlot PL; Slaney J; Toseland PA
    Br Med J; 1977 Jul; 2(6080):159-62. PubMed ID: 871824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of cellular hypersensitivity in patients with unexplained hepatitis following halothane.
    Walton B; Hamblin A; Dumonde DC; Simpson R
    Anesthesiology; 1976 May; 44(5):391-7. PubMed ID: 1267204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Halothane hepatitis in children.
    Kenna JG; Neuberger J; Mieli-Vergani G; Mowat AP; Williams R
    Br Med J (Clin Res Ed); 1987 May; 294(6581):1209-11. PubMed ID: 3109584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte cytotoxicity to halothane altered hepatocytes in patients with severe hepatic necrosis following halothane anaesthesia.
    Mieli-Vergani G; Vergani D; Tredger JM; Eddleston AL; Davis M; Williams R
    J Clin Lab Immunol; 1980 Jul; 4(1):49-51. PubMed ID: 7463474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitisation to halothane-altered liver components in severe hepatic necrosis after halothane anaesthesia.
    Vergani D; Tsantoulas D; Eddleston AL; Davis M; Williams R
    Lancet; 1978 Oct; 2(8094):801-3. PubMed ID: 81359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Halothane hepatitis.
    Neuberger J; Williams R
    Dig Dis; 1988; 6(1):52-64. PubMed ID: 3349642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Halothane hepatitis: a model of immune mediated drug hepatotoxicity.
    Neuberger J; Kenna JG
    Clin Sci (Lond); 1987 Mar; 72(3):263-70. PubMed ID: 3545644
    [No Abstract]   [Full Text] [Related]  

  • 8. [A case of fulminant hepatitis after reexposure to halothane six years later].
    Koizumi T; Kambayashi T; Ichiyoshi T; Nakamura M; Ogihara M
    Masui; 1989 Sep; 38(9):1212-6. PubMed ID: 2810719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological aspects of halothane hepatitis. Possible relevance of biotransformation.
    Walton B
    Acta Anaesthesiol Belg; 1975; 23 Suppl():155-9. PubMed ID: 1231479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for halothane hepatitis.
    Cousins MJ; Plummer JL; Hall PD
    Aust N Z J Surg; 1989 Jan; 59(1):5-14. PubMed ID: 2643940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating immune complexes in patients with fulminant hepatic failure.
    Canalese J; Wyke RJ; Vergani D; Eddleston AL; Williams R
    Gut; 1981 Oct; 22(10):845-8. PubMed ID: 7297915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of halothane hepatitis.
    Gut J
    Arch Toxicol Suppl; 1998; 20():3-17. PubMed ID: 9442277
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum sickness and acute renal failure after streptokinase therapy for myocardial infarction.
    Davies KA; Mathieson P; Winearls CG; Rees AJ; Walport MJ
    Clin Exp Immunol; 1990 Apr; 80(1):83-8. PubMed ID: 2323103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Halothane hepatitis patients generate an antibody response toward a covalently bound metabolite of halothane.
    Hubbard AK; Roth TP; Gandolfi AJ; Brown BR; Webster NR; Nunn JF
    Anesthesiology; 1988 May; 68(5):791-6. PubMed ID: 3369720
    [No Abstract]   [Full Text] [Related]  

  • 15. Specific antibodies to halothane-induced liver antigens in halothane-associated hepatitis.
    Kenna JG; Neuberger J; Williams R
    Br J Anaesth; 1987 Oct; 59(10):1286-90. PubMed ID: 3676056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic damage after exposure to halothane in medical personnel.
    Neuberger J; Vergani D; Mieli-Vergani G; Davis M; Williams R
    Br J Anaesth; 1981 Nov; 53(11):1173-7. PubMed ID: 7326163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis after exposure to halothane.
    Klion FM; Schaffner F; Popper H
    Ann Intern Med; 1969 Sep; 71(3):467-77. PubMed ID: 5809678
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis.
    Vergani D; Mieli-Vergani G; Alberti A; Neuberger J; Eddleston AL; Davis M; Williams R
    N Engl J Med; 1980 Jul; 303(2):66-71. PubMed ID: 6991940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of anti-trifluoroacetate antibody after halothane anaesthesia in patients exhibiting no or mild liver damage.
    Sakaguchi Y; Inaba S; Irita K; Sakai H; Nawata H; Takahashi S
    Can J Anaesth; 1994 May; 41(5 Pt 1):398-403. PubMed ID: 8055607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ["Hepatitis" following halothane-anesthesia (author's transl)].
    Kreienbühl G
    Anaesthesist; 1981 Jan; 30(1):1-10. PubMed ID: 7008644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.